Prosight Management’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$3.04M Sell
2024
Q2
$6.1M Buy
2024
Q1
$3.2M Buy
2019
Q1
Sell
2018
Q4
$4.77M Buy
2018
Q3
$4.78M Buy